tradingkey.logo

BRIEF-FDA Novo Nordisk's Ozempic Injection .68 Mg/1 Ml, Injection 1.34 Mg/1 Ml, Injection 2.68 Mg/1 Ml Available As Of Feb 21 - Website

ReutersFeb 21, 2025 2:14 PM

- Novo Nordisk A/S NOVOb.CO:

  • FDA: NOVO NORDISK'S OZEMPIC INJECTION .68 MG/1 ML, INJECTION 1.34 MG/1 ML, INJECTION 2.68 MG/1 ML AVAILABLE AS OF FEB 21 - WEBSITE

  • FDA: NOVO NORDISK'S WEGOVY, INJECTION, 1.7 MG/.75 ML , WEGOVY, INJECTION, 2.4 MG/.75 ML NOW AVAILABLE- WEBSITE

  • FDA SAYS SEMAGLUTIDE INJECTION SHORTAGE IS RESOLVED AS OF FEB 21 - WEBSITE

Further company coverage: [NOVOb.CO]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI